342 related articles for article (PubMed ID: 34357480)
1. A pilot safety, tolerability and pharmacokinetic study of an oro-buccal administered cannabidiol-dominant anti-inflammatory formulation in healthy individuals: a randomized placebo-controlled single-blinded study.
Vitetta L; Butcher B; Henson JD; Rutolo D; Hall S
Inflammopharmacology; 2021 Oct; 29(5):1361-1370. PubMed ID: 34357480
[TBL] [Abstract][Full Text] [Related]
2. Pilot clinical and pharmacokinetic study of Δ9-Tetrahydrocannabinol (THC)/Cannabidiol (CBD) nanoparticle oro-buccal spray in patients with advanced cancer experiencing uncontrolled pain.
Clarke S; Butcher BE; McLachlan AJ; Henson JD; Rutolo D; Hall S; Vitetta L
PLoS One; 2022; 17(10):e0270543. PubMed ID: 36240167
[TBL] [Abstract][Full Text] [Related]
3. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Taylor L; Gidal B; Blakey G; Tayo B; Morrison G
CNS Drugs; 2018 Nov; 32(11):1053-1067. PubMed ID: 30374683
[TBL] [Abstract][Full Text] [Related]
4. A Phase 1, Randomised, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Cannabidiol in Fed Healthy Volunteers.
Perkins D; Butler J; Ong K; Nguyen TH; Cox S; Francis B; Mcintosh M; Lilley B
Eur J Drug Metab Pharmacokinet; 2020 Oct; 45(5):575-586. PubMed ID: 32409982
[TBL] [Abstract][Full Text] [Related]
5. Safety and tolerability of escalating cannabinoid doses in healthy cats.
Kulpa JE; Paulionis LJ; Eglit GM; Vaughn DM
J Feline Med Surg; 2021 Dec; 23(12):1162-1175. PubMed ID: 33769105
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of the safety, tolerability and pharmacokinetics of cannabidiol administered as single-dose oil solution and single and multiple doses of a sublingual wafer in healthy volunteers.
Hosseini A; McLachlan AJ; Lickliter JD
Br J Clin Pharmacol; 2021 Apr; 87(4):2070-2077. PubMed ID: 33075170
[TBL] [Abstract][Full Text] [Related]
7. Single-Dose Pharmacokinetics of Oral Cannabidiol Following Administration of PTL101: A New Formulation Based on Gelatin Matrix Pellets Technology.
Atsmon J; Heffetz D; Deutsch L; Deutsch F; Sacks H
Clin Pharmacol Drug Dev; 2018 Sep; 7(7):751-758. PubMed ID: 29125702
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pharmacokinetics and acute anti-inflammatory potential of two oral cannabidiol preparations in healthy adults.
Hobbs JM; Vazquez AR; Remijan ND; Trotter RE; McMillan TV; Freedman KE; Wei Y; Woelfel KA; Arnold OR; Wolfe LM; Johnson SA; Weir TL
Phytother Res; 2020 Jul; 34(7):1696-1703. PubMed ID: 32147925
[TBL] [Abstract][Full Text] [Related]
9. PTL401, a New Formulation Based on Pro-Nano Dispersion Technology, Improves Oral Cannabinoids Bioavailability in Healthy Volunteers.
Atsmon J; Cherniakov I; Izgelov D; Hoffman A; Domb AJ; Deutsch L; Deutsch F; Heffetz D; Sacks H
J Pharm Sci; 2018 May; 107(5):1423-1429. PubMed ID: 29287930
[TBL] [Abstract][Full Text] [Related]
10. Piperine-pro-nanolipospheres as a novel oral delivery system of cannabinoids: Pharmacokinetic evaluation in healthy volunteers in comparison to buccal spray administration.
Cherniakov I; Izgelov D; Barasch D; Davidson E; Domb AJ; Hoffman A
J Control Release; 2017 Nov; 266():1-7. PubMed ID: 28890215
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and effects on arachidonic acid metabolism of low doses of cannabidiol following oral administration to horses.
Ryan D; McKemie DS; Kass PH; Puschner B; Knych HK
Drug Test Anal; 2021 Jul; 13(7):1305-1317. PubMed ID: 33723919
[TBL] [Abstract][Full Text] [Related]
13. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers.
Izgelov D; Davidson E; Barasch D; Regev A; Domb AJ; Hoffman A
Eur J Pharm Biopharm; 2020 Sep; 154():108-115. PubMed ID: 32634571
[TBL] [Abstract][Full Text] [Related]
15. A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray.
Stott CG; White L; Wright S; Wilbraham D; Guy GW
Eur J Clin Pharmacol; 2013 May; 69(5):1135-47. PubMed ID: 23179176
[TBL] [Abstract][Full Text] [Related]
16. Enhancing transmucosal delivery of CBD through nanoemulsion: in vitro and in vivo studies.
Provenzano R; De Caro C; Vitiello A; Izzo L; Ritieni A; Ungaro F; Quaglia F; Russo E; Miro A; d'Angelo I
Drug Deliv Transl Res; 2024 Jun; 14(6):1648-1659. PubMed ID: 38064145
[TBL] [Abstract][Full Text] [Related]
17. The effect of Pro NanoLipospheres (PNL) formulation containing natural absorption enhancers on the oral bioavailability of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in a rat model.
Cherniakov I; Izgelov D; Domb AJ; Hoffman A
Eur J Pharm Sci; 2017 Nov; 109():21-30. PubMed ID: 28736128
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs.
Bartner LR; McGrath S; Rao S; Hyatt LK; Wittenburg LA
Can J Vet Res; 2018 Jul; 82(3):178-183. PubMed ID: 30026641
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
20. Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study.
Patrician A; Versic-Bratincevic M; Mijacika T; Banic I; Marendic M; Sutlović D; Dujić Ž; Ainslie PN
Adv Ther; 2019 Nov; 36(11):3196-3210. PubMed ID: 31512143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
